Overall, a vast majority of studies seem to suggest that there may be utility in quantifying ECP levels especially in the eosinophilic subtype of CRS, understandably so given its relationship to other diseases that feature a similar inflammatory signature such as asthma and atopic dermatitis. This evidence concerns the gene RNASE3 and asthma.